Abstract
BackgroundLaparoscopic metabolic surgery has been previously shown to be an effective treatment for obese patients with type 2 diabetes (T2DM). The objective of this scoping review is to determine the impact of metabolic surgery for the treatment of type 2 diabetes in Asia and perform an evidence-based analysis.MethodsWe performed a literature search in PubMed for research on laparoscopic metabolic surgery for the treatment of T2DM in Asia region. We classified the included studies based on the Oxford Center for Evidence Based Medicine guidelines. And performed and evidence analysis.ResultsIn total, 205 articles were identified. 62.9% of the studies were from East Asia. The evidence of 26 studies are level I, 59 are level II. Laparoscopic sleeve gastrectomy (LSG) was the most commonly reported surgical procedure (63.1%) in Asia. The number of laparoscopic metabolic surgery for T2DM in Asian countries has increased rapidly over the last 8 years. We identified 16 studies which showed that laparoscopic metabolic surgery is an effective and safe treatment for T2DM in patients with a BMI of > 25 kg/m2 to < 35 kg/m2 in Asia.ConclusionsOur results suggest that laparoscopic metabolic surgery might be an effective and safe treatment for T2DM patients with BMI < 35 kg/m2, and that LSG is the most commonly performed surgical procedure for this in Asia.
Highlights
Laparoscopic metabolic surgery has been previously shown to be an effective treatment for obese patients with type 2 diabetes (T2DM)
The major complications were incomplete intestinal obstruction, mild upper gastrointestinal bleeding, excessive postoperative suture line bleeding with shock, anastomotic ulceration, anemia, low albumin, bile reflux, excess weight loss, early hemorrhage, marginal ulcers, seromas, nausea, vomitingand diarrhea, gastric fistula and infection, all complications were cured by symptomatic treatment (Table 3). These results suggest that laparoscopic metabolic surgery may be effectively used to treat type 2 diabetes mellitus (T2DM) in patients with Body Mass Index (BMI) of > 25 kg/m2 to < 35 kg/m2 in Asia [23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38]
This study suggests that the use of laparoscopic metabolic surgery for T2DM is increasing in Asia, especially in China and India
Summary
Laparoscopic metabolic surgery has been previously shown to be an effective treatment for obese patients with type 2 diabetes (T2DM). The objective of this scoping review is to determine the impact of metabolic surgery for the treatment of type 2 diabetes in Asia and perform an evidence-based analysis. The prevalence of type 2 diabetes mellitus (T2DM) and obesity is increasing rapidly worldwide, especially in developing countries [1]. Wittgrove et al [12] performed the first five cases of laparoscopic gastric bypass surgery in 1993–1994 which showed promising results of weight loss. [13] found that bariatric surgery can significantly reduce weight In 1995, Walter Porieset al. [13] found that bariatric surgery can significantly reduce weight
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
